{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:16:36Z","timestamp":1790820996841,"version":"4.1.0"},"reference-count":79,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hubei Provincial Administration of Traditional Chinese Medicine","award":["ZY2025L037"],"award-info":[{"award-number":["ZY2025L037"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Boron neutron capture therapy (BNCT) is experiencing a global resurgence driven by advances in boron pharmacology, accelerator-based neutron sources, and molecular imaging-guided theranostics. BNCT produces high linear energy transfer particles with micrometer-range energy deposition, enabling cell-selective irradiation confined to boron-enriched tumor cells in a geometrically targeted region by the neutron beam. This mechanism offers the potential for exceptionally high therapeutic ratios, provided two core requirements are met: sufficient differential tumor uptake of 10B and a neutron beam with appropriate energy and penetration. After early clinical attempts in the mid-20th century were hindered by inadequate boron agents and reactor-based neutron beams, recent technological breakthroughs have made BNCT clinically viable. The development of hospital-compatible accelerator neutron sources, next-generation boron delivery systems (such as receptor-targeted compounds and nanoparticles), advanced theranostic approaches (such as 18F-BPA positron emission tomography and boron-sensitive magnetic resonance imaging), and AI-driven biodistribution modeling now support personalized treatment planning and patient selection. These innovations have catalyzed modern clinical implementation, exemplified by Japan\u2019s regulatory approval of BNCT for recurrent head and neck cancer and the rapid expansion of clinical programs across Asia, Europe, and South America. Building on these foundations, BNCT has transitioned from a predominantly academic experimental modality into an increasingly commercialized and industrially supported therapeutic platform. The emergence of dedicated BNCT companies, international collaborations between accelerator manufacturers and hospitals, and pharmaceutical development pipelines for next-generation boron carriers has accelerated clinical translation. Moreover, BNCT now occupies a unique position among radiation modalities due to its hybrid nature, namely combining the biological targeting of radiopharmaceutical therapy with the external-beam controllability of radiotherapy, thereby offering new therapeutic opportunities where competitive approaches fall short. Emerging evidence suggests therapeutic promise in glioblastoma, recurrent head and neck cancers, melanoma, meningioma, lung cancer, sarcomas, and other difficult-to-treat malignancies. Looking ahead, continued innovation in compact neutron source engineering, boron nanocarriers, multimodal theranostics, microdosimetry-guided treatment planning, and combination strategies with systemic therapies such as immunotherapy will be essential for optimizing outcomes. Together, these converging developments position BNCT as a biologically targeted and potentially transformative modality in the era of precision oncology.<\/jats:p>","DOI":"10.3390\/cancers18030498","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:00:58Z","timestamp":1770109258000},"page":"498","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Boron Neutron Capture Therapy: A Technology-Driven Renaissance"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-1633","authenticated-orcid":false,"given":"Dandan","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hubei Cancer Hospital, Huazhong University of Science and Technology, Wuhan 430079, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Dona Maria","family":"Lemus","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Miami, Coral Gables, FL 33146, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Podgorsak","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4306-5441","authenticated-orcid":false,"given":"Matthew","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-6953","authenticated-orcid":false,"given":"Fiona","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2004-6925","authenticated-orcid":false,"given":"Hyunuk","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8588-3380","authenticated-orcid":false,"given":"Jihyung","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Rochester, Rochester, NY 14627, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref_1","first-page":"479","article-title":"The nuclear photoelectric effect","volume":"151","author":"Chadwick","year":"1935","journal-title":"Proc. R. Soc. Lond. Ser. A-Math. Phys. Sci."},{"key":"ref_2","first-page":"1","article-title":"Biological effects and the therapeutic possibilities of neutrons","volume":"36","author":"Locher","year":"1936","journal-title":"Am. J. Roentgenol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4440877","DOI":"10.1155\/2021\/4440877","article-title":"Analysis of the Dose Drop at the Edge of the Target Area in Heavy Ion Radiotherapy","volume":"2021","author":"Ma","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/1097-0142(1955)8:3<601::AID-CNCR2820080326>3.0.CO;2-R","article-title":"Pathological study of eight patients with glioblastoma multiforme treated by neutroncapture therapy using boron 10","volume":"8","author":"Godwin","year":"1955","journal-title":"Cancer"},{"key":"ref_5","first-page":"110","article-title":"Neutron capture therapy of gliomas using boron","volume":"13","author":"Farr","year":"1954","journal-title":"Trans. Am. Neurol. Assoc."},{"key":"ref_6","first-page":"201","article-title":"Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan","volume":"38","author":"Matsumura","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sato, M., Hirose, K., Takeno, S., Aihara, T., Nihei, K., Takai, Y., Hayashi, T., Bando, K., Kimura, H., and Tsurumi, K. (2024). Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance. Cancers, 16.","DOI":"10.3390\/cancers16050869"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e7250","DOI":"10.1002\/cam4.7250","article-title":"Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real-world experiences over a 2-year period","volume":"13","author":"Takeno","year":"2024","journal-title":"Cancer Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hatanaka, H., Sano, K., and Yasukochi, H. (1992). Clinical results of boron neutron capture therapy. Progress in Neutron Capture Therapy for Cancer, Springer.","DOI":"10.1007\/978-1-4615-3384-9_124"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rpor.2014.11.004","article-title":"Present status of Accelerator-Based BNCT","volume":"21","author":"Kreiner","year":"2016","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.apradiso.2014.02.018","article-title":"Project for the development of the linac based NCT facility in University of Tsukuba","volume":"88","author":"Kumada","year":"2014","journal-title":"Appl. Radiat. Isot."},{"key":"ref_12","first-page":"251","article-title":"First human clinical trial of melanoma neutron capture: Diagnosis and therapy","volume":"165","author":"Mishima","year":"1989","journal-title":"Strahlenther. Onkol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-05-0035","article-title":"Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects","volume":"11","author":"Barth","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_14","first-page":"1061","article-title":"Boron neutron capture therapy of cancer","volume":"50","author":"Barth","year":"1990","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, L.-W., Liu, Y.-W.H., Chu, P.-Y., Liu, H.-M., Peir, J.-J., Lin, K.-H., Huang, W.-S., Lo, W.-L., Lee, J.-C., and Lin, T.-Y. (2023). Boron Neutron Capture Therapy Followed by Image-Guided Intensity-Modulated Radiotherapy for Locally Recurrent Head and Neck Cancer: A Prospective Phase I\/II Trial. Cancers, 15.","DOI":"10.3390\/cancers15102762"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.62347\/HBBE6868","article-title":"The current status and novel advances of boron neutron capture therapy clinical trials","volume":"14","author":"Zhou","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_17","first-page":"184","article-title":"From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience","volume":"38","author":"Porra","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s43673-022-00063-2","article-title":"Advances of LINAC-based boron neutron capture therapy in Korea","volume":"32","author":"Bae","year":"2022","journal-title":"AAPPS Bull."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109315","DOI":"10.1016\/j.apradiso.2020.109315","article-title":"Status of low-energy accelerator-based BNCT worldwide and in Argentina","volume":"166","author":"Cartelli","year":"2020","journal-title":"Appl. Radiat. Isot."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Asano, T., and Kirihata, M. (2025). A Commercially Available BNCT Drug: Steboronine\u00ae from Stella Pharma. Neutron Capture Therapy: Principles and Applications, Springer.","DOI":"10.1007\/978-3-031-82591-0_18"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tanaka, H., and Baba, T. (2025). Cyclotron-Based Neutron Source, Sumitomo BNCT System, \u201cNeuCure\u201d. Neutron Capture Therapy: Principles and Applications, Springer.","DOI":"10.1007\/978-3-031-82591-0_6"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Chong, Y., Liu, Y., Pan, J., Huang, C., Sun, Q., Liu, Z., Zhu, X., Shao, Y., and Jin, C. (2023). A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China. Cancers, 15.","DOI":"10.3390\/cancers15164060"},{"key":"ref_23","unstructured":"Sciences TAEL, and Stella, P. (2026, January 19). TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe: TAE Life Sciences. 2024 [Updated 13 November 2024]. Available online: https:\/\/taelifesciences.com\/tae-life-sciences-and-stella-pharma-announce-strategic-agreement-for-development-and-commercialization-of-bpa-for-bnct-cancer-therapy-in-the-usa-and-europe\/."},{"key":"ref_24","unstructured":"Sciences TAEL, and University of WM (2026, January 19). TAE Life Sciences and University of Wisconsin\u2013Madison to Bring Promising Accelerator-Based BNCT Cancer Treatment to the USA: BioSpace\/Business Wire. 2025 [Updated 25 September 2025]. Available online: https:\/\/www.biospace.com\/press-releases\/tae-life-sciences-and-university-of-wisconsin-madison-to-bring-promising-accelerator-based-bnct-cancer-treatment-to-the-usa."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ijrobp.2024.03.041","article-title":"Clinical Results and Prognostic Factors in Boron Neutron Capture Therapy for Recurrent Squamous Cell Carcinoma of the Head and Neck Under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients","volume":"120","author":"Hirose","year":"2024","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101897","DOI":"10.1016\/j.adro.2025.101897","article-title":"Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control","volume":"10","author":"Hong","year":"2025","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13014-021-01939-7","article-title":"The basis and advances in clinical application of boron neutron capture therapy","volume":"16","author":"He","year":"2021","journal-title":"Radiat. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Sauerwein, W.A.G., Sancey, L., Hey-Hawkins, E., Kellert, M., Panza, L., Imperio, D., Balcerzyk, M., Rizzo, G., Scalco, E., and Herrmann, K. (2021). Theranostics in boron neutron capture therapy. Life, 11.","DOI":"10.3390\/life11040330"},{"key":"ref_30","unstructured":"IAEA (2023). Advances in Boron Neutron Capture Therapy, International Atomic Energy Agency."},{"key":"ref_31","unstructured":"Yoshioka, M. (2016). Review of Accelerator-based Boron Neutron Capture Therapy Machines. IPAC2016 Proceedings, JACoW."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mitsumoto, T., Yajima, S., Tsutsui, H., Ogasawara, T., Fujita, K., Tanaka, H., Sakurai, Y., and Maruhashi, A. (2013). Cyclotron-based neutron source for BNCT. AIP Conference Proceedings, American Institute of Physics.","DOI":"10.1063\/1.4802341"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1140\/epjti\/s40485-023-00105-5","article-title":"Current development status of accelerator-based neutron source for boron neutron capture therapy","volume":"10","author":"Kumada","year":"2023","journal-title":"EPJ Tech. Instrum."},{"key":"ref_34","unstructured":"IAEA (2001). Current Status of Neutron Capture Therapy. IAEA-TECDOC-1223, IAEA."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"170126","DOI":"10.1016\/j.nima.2024.170126","article-title":"Clinical evaluation of performance, stability, and longevity of an accelerator system designed for boron neutron capture therapy utilising a beryllium target","volume":"1072","author":"Hu","year":"2024","journal-title":"Nucl. Instrum. Methods Phys. Res. Sect. A Accel. Spectrometers Detect. Assoc. Equip."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1016\/j.apradiso.2009.03.096","article-title":"Improvement of dose distribution in phantom by using epithermal neutron source based on the Be(p,n) reaction using a 30 MeV proton cyclotron accelerator","volume":"67","author":"Tanaka","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111249","DOI":"10.1016\/j.apradiso.2024.111249","article-title":"Performance evaluation of a 71Ga(n,\u03b3)72Ga reaction-based epithermal neutron flux detector at an AB-BNCT device","volume":"207","author":"Guan","year":"2024","journal-title":"Appl. Radiat. Isot."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"050013","DOI":"10.1063\/1.5127705","article-title":"Beam performance of the iBNCT as a compact linac-based BNCT neutron source developed by University of tsukuba","volume":"2160","author":"Kumada","year":"2019","journal-title":"AIP Conf. Proc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.36922\/ARNM025190022","article-title":"Performance of neutron beam system for accelerator-based boron neutron capture therapy","volume":"3","author":"Veksleman","year":"2025","journal-title":"Adv. Radiother. Nucl. Med."},{"key":"ref_40","unstructured":"Sciences TAEL (2026, January 19). TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT). Available online: https:\/\/firstwordpharma.com\/story\/5706513."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Fukumitsu, N., and Matsumoto, Y. (2021). Development of an Imaging Technique for Boron Neutron Capture Therapy. Cells, 10.","DOI":"10.3390\/cells10082135"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0883-2889(91)90133-L","article-title":"Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-d,l-phenylalanine: A target compound for PET and boron neutron capture therapy","volume":"42","author":"Ishiwata","year":"1991","journal-title":"Int. J. Radiat. Appl. Instrum. Part A Appl. Radiat. Isot."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.apradiso.2011.02.046","article-title":"Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention","volume":"69","author":"Wittig","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15741","DOI":"10.1038\/s41598-023-42284-x","article-title":"Correcting for the heterogeneous boron distribution in a tumor for BNCT dose calculation","volume":"13","author":"Teng","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1021\/acs.jmedchem.3c01265","article-title":"Boronotyrosine, a Borylated Amino Acid Mimetic with Enhanced Solubility, Tumor Boron Delivery, and Retention for the Re-emerging Boron Neutron Capture Therapy Field","volume":"66","author":"Raitano","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"31285","DOI":"10.1038\/s41598-025-14642-4","article-title":"MRI and 18F-BPA PET-guided targeting in boron neutron capture therapy","volume":"15","author":"Hu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Seneviratne, D.S., Saifi, O., Mackeyev, Y., Malouff, T., and Krishnan, S. (2023). Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT. Cells, 12.","DOI":"10.3390\/cells12101398"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/med.21964","article-title":"Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment","volume":"43","author":"Coghi","year":"2023","journal-title":"Med. Res. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"101947","DOI":"10.1016\/j.adro.2025.101947","article-title":"Boron Neutron Capture Therapy in Recurrent High-Grade Gliomas: Safety, Efficacy, and Pharmacokinetics From a Multicenter, Dose-Escalation Phase 1 Trial","volume":"11","author":"Kim","year":"2025","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Oloo, S.O., Smith, K.M., and Vicente, M.d.G.H. (2023). Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers. Cancers, 15.","DOI":"10.3390\/cancers15133277"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7150\/thno.123376","article-title":"State-of-the-art boron clusters for boron neutron-capture therapy","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"J\u00e4rvinen, J., Pulkkinen, H., Rautio, J., and Timonen, J.M. (2023). Amino Acid-Based Boron Carriers in Boron Neutron Capture Therapy (BNCT). Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15122663"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Monti Hughes, A., and Hu, N. (2023). Optimizing boron neutron capture therapy (BNCT) to treat cancer: An updated review on the latest developments on boron compounds and strategies. Cancers, 15.","DOI":"10.3390\/cancers15164091"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12149-019-01347-8","article-title":"4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: Overview of a quarter century of research","volume":"33","author":"Ishiwata","year":"2019","journal-title":"Ann. Nucl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"111720","DOI":"10.1016\/j.apradiso.2025.111720","article-title":"Comparison of dose distribution with and without reflecting heterogeneous boron distribution using 18F-BPA positron emission tomography in boron neutron capture therapy","volume":"219","author":"Kobayashi","year":"2025","journal-title":"Appl. Radiat. Isot."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10147-013-0580-3","article-title":"Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck","volume":"19","author":"Aihara","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.21037\/qims-23-1769","article-title":"Prognostic assessment of 18F-boronophenylalanine positron emission tomography (BPA-PET) in salvage boron neutron capture therapy for malignant brain tumors","volume":"14","author":"Lin","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1016\/j.apradiso.2009.03.065","article-title":"In vivo 19F MR imaging and spectroscopy for the BNCT optimization","volume":"67","author":"Porcari","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1038\/s41598-024-63248-9","article-title":"The impact of ZTE-based MR attenuation correction compared to CT-AC in 18F-FBPA PET before boron neutron capture therapy","volume":"14","author":"Lo","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"116841","DOI":"10.1016\/j.ejmech.2024.116841","article-title":"In silico assessments of the small molecular boron agents to pave the way for artificial intelligence-based boron neutron capture therapy","volume":"279","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jrr\/rraf038","article-title":"Research on the dose calculation of BNCT based on the time-varying boron concentration in pharmacokinetics","volume":"66","author":"Chen","year":"2025","journal-title":"J. Radiat. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1002\/mp.16215","article-title":"Use of a neural network-based prediction method to calculate the therapeutic dose in boron neutron capture therapy of patients with glioblastoma","volume":"50","author":"Tian","year":"2023","journal-title":"Med. Phys."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Liao, C.-Y., Jen, J.-H., Chen, Y.-W., Li, C.-Y., Wang, L.-W., Liu, R.-S., Huang, W.-S., and Lu, C.-F. (2021). Comparison of Conventional and Radiomic Features between 18F-FBPA PET\/CT and PET\/MR. Biomolecules, 11.","DOI":"10.3390\/biom11111659"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.apradiso.2004.05.059","article-title":"Effectiveness of BNCT for recurrent head and neck malignancies","volume":"61","author":"Kato","year":"2004","journal-title":"Appl. Radiat. Isot."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hed.20418","article-title":"First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET","volume":"28","author":"Aihara","year":"2006","journal-title":"Head Neck"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.anl.2024.06.007","article-title":"Boron neutron capture therapy as a larynx-preserving treatment for locally recurrent laryngeal carcinoma after conventional radiation therapy: A preliminary report","volume":"51","author":"Higashino","year":"2024","journal-title":"Auris Nasus Larynx"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.apradiso.2011.05.029","article-title":"Clinical results of boron neutron capture therapy (BNCT) for glioblastoma","volume":"69","author":"Kageji","year":"2011","journal-title":"Appl. Radiat. Isot."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"vdab067","DOI":"10.1093\/noajnl\/vdab067","article-title":"Accelerator-based BNCT for patients with recurrent glioblastoma: A multicenter phase II study","volume":"3","author":"Kawabata","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"112152","DOI":"10.1016\/j.apradiso.2025.112152","article-title":"Boron neutron capture therapy (BNCT) phase I clinical trial for newly diagnosed glioblastoma by newly developed accelerator at University of Tsukuba","volume":"226","author":"Nakai","year":"2025","journal-title":"Appl. Radiat. Isot."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/neuonc\/noab108","article-title":"Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up","volume":"24","author":"Takai","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ejmp.2014.07.342","article-title":"Exploring Boron Neutron Capture Therapy for non-small cell lung cancer","volume":"30","author":"Bortolussi","year":"2014","journal-title":"Phys. Medica"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lan, T.-L., Lin, C.-F., Lee, Y.-Y., Lin, K.-H., Chang, F.-C., Lin, S.-C., Lee, J.-C., Chou, F.-I., Peir, J.-J., and Liu, H.-M. (2023). Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054978"},{"key":"ref_73","first-page":"e57417","article-title":"The Effects of Boron Neutron Capture Therapy on the Lungs in Recurrent Breast Cancer Treatment","volume":"16","author":"Kurosaki","year":"2024","journal-title":"Cureus"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13691-012-0048-8","article-title":"Reirradiation for locally recurrent lung cancer in the chest wall with boron neutron capture therapy (BNCT)","volume":"1","author":"Suzuki","year":"2012","journal-title":"Int. Cancer Conf. J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1023230801571","article-title":"Boron neutron capture therapy for glioblastoma multiforme: Clinical studies in Sweden","volume":"62","author":"Capala","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1023293006617","article-title":"Boron neutron capture therapy of brain tumors: Clinical trials at the Finnish facility using boronophenylalanine","volume":"62","author":"Joensuu","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.apradiso.2004.05.060","article-title":"First BNCT treatment of a skin melanoma in Argentina: Dosimetric analysis and clinical outcome","volume":"61","author":"Bonomi","year":"2004","journal-title":"Appl. Radiat. Isot."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jrr\/rraa068","article-title":"Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)","volume":"61","author":"Hiratsuka","year":"2020","journal-title":"J. Radiat. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"110607","DOI":"10.1016\/j.radonc.2024.110607","article-title":"Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial","volume":"202","author":"Kashihara","year":"2024","journal-title":"Radiother. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/498\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:11:03Z","timestamp":1770109863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":79,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030498"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030498","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}